PSYC 6640 Week 10 iHuman assignment guide

Read the four questions before the vignette, because the vignette will pull you the wrong way. Describe the evaluation tool; apply scholarly research to its validity and reliability; apply the tool to a patient situation; describe a plan of care depending on the results. Three of the four are about an instrument, and Angela appears in only one of them. What most submissions produce instead is a case write-up — history, findings, diagnosis, treatment — with the tool mentioned once in passing. That answers a different assignment. Name the instrument in your first sentence, keep it as the subject of the paragraph throughout, and let the case be the setting in which you demonstrate it rather than the thing being described. The quickest test is to read your draft and count how many paragraphs have the instrument as their grammatical subject. If it is fewer than half, rewrite.

Validity and reliability are not synonyms and the second question asks for both, from scholarly research rather than from assertion. Validity is whether the instrument measures the disorder it claims to — reported as sensitivity, specificity and agreement against a structured clinical interview, at a stated cut-off. Reliability is whether it gives a stable answer — internal consistency and test-retest. A screening instrument can be reliable and invalid, returning the same wrong answer every time. Give the numbers and the cut-off you are relying on, because a score means nothing without one, and say what population the validation sample was drawn from. An instrument validated in primary care behaves differently in a specialty clinic where the base rate of disorder is far higher. A cut-off validated at one prevalence performs differently at another, and saying so is a mark of having read the paper.

There is a real collision between two of the brief's own instructions and you should resolve it deliberately rather than by accident. It asks for references no older than five years, and the psychometric evidence for an established adolescent screening instrument comes from its original validation study, which is considerably older than that. You cannot report sensitivity and specificity from a source that never measured them. Cite the validation study for the instrument's development and psychometrics, and use current sources — the preventive services recommendation, the primary care guidelines, recent psychometric replications — for everything about how it is used now. Say in a sentence that you have done this and why. That reads as judgement; silently breaking the rule reads as not having noticed it. One sentence is enough, and it converts an apparent rule break into a demonstration that you know where evidence comes from.

The vignette is doing something the model answers usually miss. Alongside the mood symptoms it lists an elevated BMI, acne, abdominal and buttock striae, and acanthosis nigricans — and those are not depression findings. Acanthosis nigricans is a marker of insulin resistance, and the combination of weight gain, fatigue, mood change and striae in an adolescent also fits hypothyroidism and, less commonly, Cushing syndrome. A high score on a depression screen does not exclude any of them, because the instrument was never designed to. The discriminating detail is growth: rapid weight gain in ordinary obesity comes with normal or accelerated height velocity, while Cushing syndrome slows it. Say what you would check before attributing everything to a mood disorder. Thyroid function and a metabolic screen are the cheap answers here, and naming them costs you two lines. The point is not to diagnose in a written assignment; it is to show you did not let a questionnaire close the differential.

The plan of care has two components that get skipped. First, denying active suicidal thoughts is a statement about one moment, not a completed risk assessment — the adolescent depression guidelines expect a safety plan to be established as part of initial management, with means restriction discussed, and the vignette's own screening questions include one about firearms in the home for exactly that reason. Second, if pharmacotherapy is part of your plan, the boxed warning on antidepressants and suicidality in people under twenty-five has to be discussed with the patient and the family and documented, along with the monitoring schedule that follows from it. Both belong in the plan whatever the score was. Neither is optional, and both are the difference between a plan and a referral with a sentence attached. Give the interval in weeks rather than saying follow-up will be arranged.